SDGR (Schrodinger) Short-Term Debt: $0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SDGR Schrodinger Inc SDGR
73 GF Score
Price $17.82
GF Value $25.98
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Schrodinger Short-Term Debt?

Schrodinger SDGR +8.56% 73 Short-Term Debt is $0.0 Mil as of Jun. 2026. GuruFocus rates SDGR with a GF Score™ of 73/100 and a GF Value™ of $25.98 (Possible Value Trap). The stock has 4 warning signs investors should review.

Schrodinger's Short-Term Debt for the quarter that ended in Jun. 2026 was $0.0 Mil.

Schrodinger Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Schrodinger Short-Term Debt Related Terms

Schrodinger Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Schrodinger's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schrodinger Short-Term Debt Chart

Schrodinger Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Schrodinger Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SDGR
73GF Score
Schrodinger Inc SDGR
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.0 Mil mean?
Schrodinger (SDGR) has a Short-Term Debt of $0.0 Mil as of Jun. 2026.
Is Schrodinger's Short-Term Debt too high?
Schrodinger's current Short-Term Debt is $0.0 Mil. Overall, Schrodinger has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Schrodinger's Short-Term Debt compare to CERT and OMDA?
Schrodinger's Short-Term Debt of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Schrodinger's current Short-Term Debt is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schrodinger stock overvalued right now?
Based on GuruFocus' analysis, Schrodinger (SDGR) is currently considered Possible Value Trap. The stock's GF Value™ is $25.98, compared to a current price of $17.82 — trading 31.4% below its estimated fair value. The current Short-Term Debt is $0.0 Mil. Schrodinger's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Schrodinger (SDGR), the current Short-Term Debt is $0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Schrodinger (SDGR) Overvalued in 2026?

Based on GuruFocus' analysis, Schrodinger stock appears to be undervalued. The current stock price of $17.82 is trading 31.4% below its estimated GF Value™ of $25.98. GuruFocus considers Schrodinger to be Possible Value Trap.

Key valuation signals for SDGR:

  • Short-Term Debt: $0.0 Mil
  • GF Value™: $25.98 vs. price of $17.82 (31.4% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the SDGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Schrodinger Business Description

Other Exchanges 43Z:Germany
Address 1540 Broadway, 24th Floor, New York, NY, USA, 10036
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
73GF Score

Get the complete analysis for SDGR

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.82
Price
$25.98
GF Value